Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19

Overview of attention for article published in Critical Care, September 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 2 blogs

twitter: 11 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 15 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 45,047 followers.

RT @vipintukur: Previously, it is shown that measuring SARS-CoV-2 nucleocapsid antigen levels in plasma may be a reliable method for detect…

09 Jan 2024

Reply Repost Favourite

RT @vipintukur: Previously, it is shown that measuring SARS-CoV-2 nucleocapsid antigen levels in plasma may be a reliable method for detect…

07 Jan 2024

Reply Repost Favourite

RT @vipintukur: Previously, it is shown that measuring SARS-CoV-2 nucleocapsid antigen levels in plasma may be a reliable method for detect…

07 Jan 2024

Reply Repost Favourite

Wick, K.D., Leligdowicz, A., Willmore, A. et al. Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19. Crit Care 26, 278 (2022). https://t.co/K5LxdpNDCe

07 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.